Cost of Illness < Cost-Benefit Analysis < Costs and Cost Analysis

Facettes : Author.f

List of bibliographic references

Number of relevant bibliographic references: 29.
[0-20] [0 - 20][0 - 29][20-28][20-40]

Ident.	Authors (with country if any)	Title
000049 (2010)	Denise Lawrie ; George Janossy ; Maarten Roos ; Deborah K. Glencross	Comprehensive & cost effective laboratory monitoring of HIV/AIDS: an African role model.
000087 (2010)	Lawrence Long ; Matthew Fox ; Ian Sanne ; Sydney Rosen	The high cost of second-line antiretroviral therapy for HIV/AIDS in South Africa.
000250 (2010)	John M. Kaldor ; David P. Wilson	How low can you go: the impact of a modestly effective HIV vaccine compared with male circumcision.
000336 (2010)	Eugene Athan ; Daniel P. O'Brien ; Rosa Legood	Cost-effectiveness of routine and low-cost CD4 T-cell count compared with WHO clinical staging of HIV to guide initiation of antiretroviral therapy in resource-limited settings.
000372 (2010)	Elioda Tumwesigye ; Goodwill Wana ; Simon Kasasa ; Elly Muganzi ; Fred Nuwaha	High uptake of home-based, district-wide, HIV counseling and testing in Uganda.
000944 (2017)	Naseem Cassim ; Kathryn Schnippel ; Lindi Marie Coetzee ; Deborah Kim Glencross	Establishing a cost-per-result of laboratory-based, reflex Cryptococcal antigenaemia screening (CrAg) in HIV+ patients with CD4 counts less than 100 cells/μl using a Lateral Flow Assay (LFA) at a typical busy CD4 laboratory in South Africa.
000982 (2017)	Omar Galárraga ; Burke Gao ; Benson N. Gakinya ; Debra A. Klein ; Richard G. Wamai ; John E. Sidle ; Rebecca K. Papas	Task-shifting alcohol interventions for HIV+ persons in Kenya: a cost-benefit analysis.
000A49 (2017)	Gavin George ; Michael Strauss ; Elias Asfaw	The cost of demand creation activities and voluntary medical male circumcision targeting school-going adolescents in KwaZulu-Natal, South Africa.
000F00 (2017)	Elias Asfaw Zegeye ; Josue Mbonigaba ; Sylvia Blanche Kaye ; Thomas Wilkinson	Economic Evaluation in Ethiopian Healthcare Sector Decision Making: Perception, Practice and Barriers.
001014 (2013)	Julie H. Levison ; Robin Wood ; Callie A. Scott ; Andrea L. Ciaranello ; Neil A. Martinson ; Corina Rusu ; Elena Losina ; Kenneth A. Freedberg ; Rochelle P. Walensky	The clinical and economic impact of genotype testing at first-line antiretroviral therapy failure for HIV-infected patients in South Africa.
001082 (2013)	Karen Schneider ; Chidi Nwizu ; Richard Kaplan ; Jonathan Anderson ; David P. Wilson ; Sean Emery ; David A. Cooper ; Mark A. Boyd	The potential cost and benefits of raltegravir in simplified second-line therapy among HIV infected patients in Nigeria and South Africa.
001138 (2013)	Garry R. Barton ; Lara Fairall ; Max O. Bachmann ; Kerry Uebel ; Venessa Timmerman ; Carl Lombard ; Merrick Zwarenstein	Cost-effectiveness of nurse-led versus doctor-led antiretroviral treatment in South Africa: pragmatic cluster randomised trial.
001159 (2013)	Kazeem O. Okosun ; Oluwole D. Makinde ; Isaac Takaidza	Analysis of recruitment and industrial human resources management for optimal productivity in the presence of the HIV/AIDS epidemic.
001218 (2014)	Jeffrey W. Eaton ; Nicolas A. Menzies ; John Stover ; Valentina Cambiano ; Leonid Chindelevitch ; Anne Cori ; Jan A C. Hontelez ; Salal Humair ; Cliff C. Kerr ; Daniel J. Klein ; Sharmistha Mishra ; Kate M. Mitchell ; Brooke E. Nichols ; Peter Vickerman ; Roel Bakker ; Till B Rnighausen ; Anna Bershteyn ; David E. Bloom ; Marie-Claude Boily ; Stewart T. Chang ; Ted Cohen ; Peter J. Dodd ; Christophe Fraser ; Chaitra Gopalappa ; Jens Lundgren ; Natasha K. Martin ; Evelinn Mikkelsen ; Elisa Mountain ; Quang D. Pham ; Michael Pickles ; Andrew Phillips ; Lucy Platt ; Carel Pretorius ; Holly J. Prudden ; Joshua A. Salomon ; David A M C. Van De Vijver ; Sake J. De Vlas ; Bradley G. Wagner ; Richard G. White ; David P. Wilson ; Lei Zhang ; John Blandford ; Gesine Meyer-Rath ; Michelle Remme ; Paul Revill ; Nalinee Sangrujee ; Fern Terris-Prestholt ; Meg Doherty ; Nathan Shaffer ; Philippa J. Easterbrook ; Gottfried Hirnschall ; Timothy B. Hallett	Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.
001242 (2013)	Sebastian Kevany ; Solomon R. Benatar ; Theodore Fleischer	Improving resource allocation decisions for health and HIV programmes in South Africa: Bioethical, cost-effectiveness and health diplomacy considerations.
001248 (2013)	Thu-Ha Dinh ; Mary L. Kamb ; Veerle Msimang ; Muptal Likibi ; Thabo Molebatsi ; Thurma Goldman ; David A. Lewis	Integration of preventing mother-to-child transmission of HIV and syphilis testing and treatment in antenatal care services in the Northern Cape and Gauteng provinces, South Africa.
001274 (2013)	Avinash K. Shetty	Epidemiology of HIV infection in women and children: a global perspective.
001302 (2013)	Joseph N. Jarvis ; Thomas S. Harrison ; Stephen D. Lawn ; Graeme Meintjes ; Robin Wood ; Susan Cleary	Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa.
001316 (2014)	Michael D. April ; Robin Wood ; Bethany K. Berkowitz ; A David Paltiel ; Xavier Anglaret ; Elena Losina ; Kenneth A. Freedberg ; Rochelle P. Walensky	The survival benefits of antiretroviral therapy in South Africa.
001400 (2013)	Noreen Dadirai Mdege ; Stanley Chindove ; Shehzad Ali	The effectiveness and cost implications of task-shifting in the delivery of antiretroviral therapy to HIV-infected patients: a systematic review.
001404 (2013)	Ide Cremin ; Ramzi Alsallaq ; Mark Dybul ; Peter Piot ; Geoffrey Garnett ; Timothy B. Hallett	The new role of antiretrovirals in combination HIV prevention: a mathematical modelling analysis.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/PubMed/Corpus

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i -k "Cost-Benefit Analysis" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i  \
                -Sk "Cost-Benefit Analysis" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaSubSaharaV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Cost-Benefit Analysis
}}

---

This area was generated with Dilib version V0.6.32. Data generation: Mon Nov 13 19:31:10 2017. Site generation: Wed Mar 6 19:14:32 2024